PriceTargets.com logo

NASDAQ:CUTR - Cutera Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $61.67
  • Forecasted Upside: 54.71 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$39.86 As of 11/26/2021 01:00 AM ET
▼ -0.21 (-0.52%)

This chart shows the closing price for CUTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cutera Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CUTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CUTR

Analyst Price Target is $61.67
▲ +54.71% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Cutera in the last 3 months. The average price target is $61.67, with a high forecast of $65.00 and a low forecast of $60.00. The average price target represents a 54.71% upside from the last price of $39.86.

This chart shows the closing price for CUTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Cutera. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/5/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/3/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/2/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/31/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/29/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/4/2021Maxim GroupUpgradeHold ➝ Buy$60.00High
8/5/2021Piper SandlerBoost Price TargetOverweight$42.00 ➝ $65.00High
7/13/2021Cantor FitzgeraldBoost Price TargetOverweight$55.00 ➝ $60.00Low
6/2/2021Cantor FitzgeraldInitiated CoverageOverweight$55.00High
3/5/2021Piper SandlerBoost Price TargetOverweight$38.00 ➝ $42.00High
2/18/2021Piper SandlerBoost Price TargetOverweight$28.00 ➝ $38.00High
11/5/2020Piper SandlerBoost Price TargetOverweight$22.00 ➝ $28.00High
9/30/2020Piper SandlerBoost Price TargetOverweight$18.00 ➝ $22.00High
9/14/2020StephensBoost Price TargetOverweight$18.00 ➝ $24.00High
5/8/2020Maxim GroupReiterated RatingHoldLow
5/5/2020Stifel NicolausUpgradeHold ➝ Buy$32.00 ➝ $26.00High
4/22/2020Piper SandlerInitiated CoverageOverweight$18.00Low
3/23/2020StephensLower Price TargetOverweight$45.00 ➝ $15.00High
2/28/2020Maxim GroupReiterated RatingHoldMedium
11/8/2019StephensBoost Price TargetOverweight$35.00 ➝ $45.00High
8/22/2019SidotiDowngradeBuy ➝ NeutralHigh
8/9/2019Maxim GroupReiterated RatingHoldLow
2/21/2019StephensLower Price TargetOverweight$40.00 ➝ $25.00High
2/11/2019Maxim GroupReiterated RatingHoldMedium
1/8/2019Maxim GroupReiterated RatingHoldHigh
10/5/2018SidotiSet Price TargetBuy$50.00High
10/5/2018StephensLower Price TargetUnderperform ➝ Sell$40.00 ➝ $24.94High
10/5/2018Stifel NicolausLower Price TargetHold ➝ Hold$45.00 ➝ $29.00High
8/8/2018Stifel NicolausLower Price TargetHold ➝ Hold$55.00 ➝ $45.00High
4/16/2018Stifel NicolausInitiated CoverageHold ➝ Hold$55.00High
3/13/2018StephensInitiated CoverageOverweight$60.00High
2/16/2018GabelliReiterated RatingBuyLow
11/8/2017Maxim GroupReiterated RatingHoldN/A
9/14/2017Maxim GroupDowngradeBuy ➝ HoldLow
9/12/2017Roth CapitalBoost Price TargetBuy$41.00 ➝ $47.00High
8/9/2017GabelliReiterated RatingBuyHigh
8/8/2017Roth CapitalBoost Price TargetBuy$32.00 ➝ $39.00High
7/13/2017Maxim GroupReiterated RatingBuy ➝ Buy$27.00 ➝ $33.00Low
7/7/2017SidotiReiterated RatingBuy$30.00 ➝ $32.00Medium
6/26/2017Roth CapitalInitiated CoverageBuy$32.00High
6/3/2017SidotiReiterated RatingBuy$27.00 ➝ $30.00Low
4/11/2017SidotiInitiated CoverageBuy ➝ Buy$27.00High
1/4/2017Maxim GroupBoost Price TargetBuy$18.00 ➝ $22.00N/A
(Data available from 11/28/2016 forward)

News Sentiment Rating

0.13 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/2/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/1/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/1/2021
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/31/2021
  • 3 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/30/2021
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2021
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/29/2021
  • 2 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2021

Current Sentiment

  • 2 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Cutera logo
Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
Read More

Today's Range

Now: $39.86
Low: $38.21
High: $40.15

50 Day Range

MA: $45.09
Low: $39.86
High: $51.49

52 Week Range

Now: $39.86
Low: $19.88
High: $60.35

Volume

105,279 shs

Average Volume

195,807 shs

Market Capitalization

$715.77 million

P/E Ratio

97.22

Dividend Yield

N/A

Beta

1.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Cutera?

The following sell-side analysts have issued stock ratings on Cutera in the last twelve months: Cantor Fitzgerald, Maxim Group, Piper Sandler, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CUTR.

What is the current price target for Cutera?

3 Wall Street analysts have set twelve-month price targets for Cutera in the last year. Their average twelve-month price target is $61.67, suggesting a possible upside of 54.7%. Piper Sandler has the highest price target set, predicting CUTR will reach $65.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $60.00 for Cutera in the next year.
View the latest price targets for CUTR.

What is the current consensus analyst rating for Cutera?

Cutera currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CUTR will outperform the market and that investors should add to their positions of Cutera.
View the latest ratings for CUTR.

What other companies compete with Cutera?

Other companies that are similar to Cutera include Outset Medical, BioLife Solutions, ViewRay, Natus Medical, Semler Scientific, TransMedics Group, Zynex, Stereotaxis, AxoGen, Edap Tms, Movano, FONAR, BioSig Technologies, IRIDEX and Electromed.

How do I contact Cutera's investor relations team?

Cutera's physical mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company's listed phone number is (415) 657-5500 and its investor relations email address is [email protected] The official website for Cutera is www.cutera.com.